Categories
Health Care

Ministry of health to push domestic medical tech

China’s ministry of health stated on Monday that it will seek to speed up the development of the country’s medical device industry and promote wider use of local products to “effectively control unreasonable increases in the cost of medical care and reduce the burden on patients,” Reuters reported. Incentives to encourage hospitals to use Chinese-made […]

Categories
Consumer Health Care Law & Regulation

Johnson & Johnson hit with price-fixing fine in China

Johnson & Johnson (JNJ.NYSE) and Bausch & Lomb (VRX.NYSE) were among companies fined a combined US$3 million (RMB19.6 million) for price fixing in China’s contact lens and eye-glasses market, Bloomberg reported. Essilor International (EI.EPA), Nikon (7731.TYO), Carl Zeiss Meditec (AFX.ETR) were also among the targets, with Hoya (7741.TYO) and Shanghai Weicon Optics exempted from punishment […]

Categories
Health Care Investment Law & Regulation

China to relax foreign investment in hospitals

China will ease curbs on foreign investment in joint-venture hospitals as part of a sweeping healthcare overhaul aimed at cuttings costs and improving services, Reuters reported, citing a plan posted on the State Council website. Plans include reducing restrictions on foreign ownership in JVs, increasing the number of locations where Hong Kong, Macau and Taiwan […]

Categories
Consumer Health Care Law & Regulation

Ex-GSK head in China charged with bribery

The British former head of drugmaker GSK’s (GSK.NYSE, GSK.LON) China operations and two other company executives have been charged by Chinese police with bribery, Reuters reported, citing a state media report on Wednesday. The three executives were charged with bribing doctors, hospitals and officials in the industry and commerce departments of Beijing and Shanghai to boost […]

Categories
Health Care Investment Markets

Fosun raises offer for Chindex to $433mn

Shanghai Fosun Pharmaceutical Group (2196.HKG) and its partners raised their offer for Maryland-based hospital operator Chindex International (CHDX.NASDAQ) to about US$433 million to counter another bidder, Bloomberg reported, citing a Monday filing from Fosun in Hong Kong. Drug maker Fosun Pharma’s venture with TPG Capital and Roberta Lipson, Chindex’s CEO and founder, boosted its bid […]